Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05541887 · ClinicalTrials.gov registry record · NA
Use Muscadine Wine Nutraceuticals to Improve Brain Health, Cognition, and Mental Health
A NA study of Anxiety and Mood, sponsored by University of Florida.
- Recruiting
- Registry status
- NA
- Development phase
- 25
- Enrollment target
- 1
- Study location
NCT05541887: Recruiting NA study of Anxiety and Mood, sponsored by University of Florida.
NCT05541887 is a NA study of Anxiety and Mood that is actively recruiting participants, run by University of Florida. The registered enrollment target is 25 participants, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05541887, a NA study of Anxiety and Mood, is actively recruiting participants, sponsored by University of Florida.
- RECRUITING
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
Previous studies have shown that polyphenol-rich foods can positively affect cognitive functions, memory, and mood in humans. We hypothesize that both acute and chronic intake of muscadine wine polyphenols will improve cognitive performance and mood through regulating the HPA axis, alleviating inflammation and oxidative stress, and/or inhibiting monoamine oxidase activities
Conditions Studied
Interventions
- OTHER Placebo
- OTHER Muscadine Wine Polyphenol
Study Locations (1)
Florida
- Food Science and human nutrition department at University of Florida - Gainesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2023-08-30 |
| Est. Completion | 2026-12 |
| Phase | NA |
What NCT05541887 shows while recruiting
NCT05541887 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (94% lower).
The record links to 4 conditions, with Anxiety appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT05541887 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT05541887 about?
NCT05541887 is a clinical study titled "Use Muscadine Wine Nutraceuticals to Improve Brain Health, Cognition, and Mental Health". Previous studies have shown that polyphenol-rich foods can positively affect cognitive functions, memory, and mood in humans. We hypothesize that both acute and chronic intake of muscadine wine polyphenols will improve cognitive performance and mood through regulating the HPA axis, alleviating infla...
What is the current status of trial NCT05541887?
This trial is currently recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2023-08-30. Estimated completion is 2026-12.
What conditions does trial NCT05541887 study?
This clinical trial studies the following conditions: Anxiety, Mood, Memory, Cognitive Performance.
What interventions are being tested in trial NCT05541887?
The interventions under investigation include: Placebo (OTHER), Muscadine Wine Polyphenol (OTHER).
Who is sponsoring clinical trial NCT05541887?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05541887 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anxiety
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05541887's enrollment target sits among peer trials
25 317th of 364 higher than 47 of 364 other Anxiety trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Anxiety trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Focused Ultrasound for the Complex Patient
RECRUITING · NA
-
Digital Intervention for Physical Activity
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Brief Interventions for Coping with Distress
RECRUITING · NA
-
Personalized Feedback Intervention for Latinx Drinkers With Anxiety
RECRUITING · NA
-
Pilot Effectiveness Trial of an ACT Self-help Workbook Tailored Specifically for Prisons
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI